Edition:
United Kingdom

Veracyte Inc (VCYT.OQ)

VCYT.OQ on NASDAQ Stock Exchange Global Market

10.92USD
17 Oct 2018
Change (% chg)

-- (--)
Prev Close
$10.92
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
97,825
52-wk High
$12.86
52-wk Low
$5.25

Latest Key Developments (Source: Significant Developments)

Veracyte Announces Public Offering Of 5 Mln Shares Priced Of $10.25 Per Share
Thursday, 26 Jul 2018 

July 25 (Reuters) - Veracyte Inc ::VERACYTE ANNOUNCES PRICING OF PUBLIC OFFERING OF 5,000,000 SHARES OF COMMON STOCK.PRICING OF UNDERWRITTEN PUBLIC OFFERING OF 5,000,000 SHARES OF ITS COMMON STOCK AT PUBLIC OFFERING PRICE OF $10.25 PER SHARE.  Full Article

Veracyte Announces Proposed Public Offering Of Common Stock
Tuesday, 24 Jul 2018 

July 24 (Reuters) - Veracyte Inc ::VERACYTE ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.SAYS OFFERING 5.00 MILLION COMMON SHARES.  Full Article

Veracyte Q2 Loss Per Share $0.18
Monday, 23 Jul 2018 

Veracyte Inc ::VERACYTE ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.18.Q2 REVENUE $22.8 MILLION VERSUS I/B/E/S VIEW $20.6 MILLION.Q2 EARNINGS PER SHARE VIEW $-0.27 -- THOMSON REUTERS I/B/E/S.SEES FY 2018 REVENUE $87 MILLION TO $89 MILLION.COMPANY IS NARROWING ITS 2018 ANNUAL CASH BURN GUIDANCE TO BETWEEN $18 MILLION AND $21 MILLION, FROM BETWEEN $18 MILLION AND $22 MILLION.SEES FY ANNUAL CASH BURN GUIDANCE TO BETWEEN $18 MILLION AND $21 MILLION.  Full Article

Veracyte Files For Mixed Shelf Of Up To $125 Million
Tuesday, 1 May 2018 

May 1 (Reuters) - Veracyte Inc ::VERACYTE INC FILES FOR MIXED SHELF OF UP TO $125 MILLION – SEC FILING.  Full Article

Veracyte Q1 Loss Per Share $0.27
Tuesday, 1 May 2018 

Veracyte Inc ::VERACYTE ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.27.Q1 REVENUE $20 MILLION VERSUS I/B/E/S VIEW $18 MILLION.SEES FY 2018 REVENUE $83 MILLION TO $86 MILLION.Q1 EARNINGS PER SHARE VIEW $-0.25 -- THOMSON REUTERS I/B/E/S.RAISES 2018 ANNUAL REVENUE GUIDANCE.REITERATES ITS ANNUAL CASH BURN GUIDANCE OF $18 MILLION TO $22 MILLION.  Full Article

Veracyte Announces Strategic Realignment And New Appointments To Advance Commercial Growth
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Veracyte Inc ::VERACYTE ANNOUNCES STRATEGIC REALIGNMENT AND NEW APPOINTMENTS TO ADVANCE COMMERCIAL GROWTH.- COMPANY REITERATES 2017 REVENUE AND CASH BURN GUIDANCE.- IS CONSOLIDATING CLINICAL, MEDICAL AND RESEARCH AND DEVELOPMENT FUNCTIONS INTO ONE DEPARTMENT.FY2017 EARNINGS PER SHARE VIEW $-0.87, REVENUE VIEW $71.3 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Veracyte posts Q3 loss per share $0.21
Monday, 6 Nov 2017 

Nov 6 (Reuters) - Veracyte Inc :Veracyte announces third quarter 2017 financial results.Q3 loss per share $0.21.Q3 revenue $17.5 million versus I/B/E/S view $19.5 million.Q3 earnings per share view $-0.23 -- Thomson Reuters I/B/E/S.Sees FY 2017 revenue $71 million to $72 million.Veracyte Inc - ‍narrowing range of its annual cash burn guidance to $25 to $26 million​.  Full Article

BRIEF-Veracyte Files For Mixed Shelf Of Up To $125 Million

* VERACYTE INC FILES FOR MIXED SHELF OF UP TO $125 MILLION – SEC FILING Source text for Eikon: (http://bit.ly/2jlv3GH) Further company coverage: